BTG2, BTG anti-proliferation factor 2, 7832

N. diseases: 77; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0595989
Disease: Carcinoma of larynx
Carcinoma of larynx
0.010 Biomarker disease BEFREE The identification of the oncogenic miR-21 and its target gene, BTG2, in laryngeal carcinoma is potentially valuable for cancer diagnosis and therapy. 19546886 2009